NASDAQ, TSX: NVCN
VANCOUVER, Nov. 10, 2017 /PRNewswire/ - Neovasc
Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN)
today announced that it will release its financial results for the
third quarter 2017 on Tuesday, November 14, 2017, after
markets close. The Company will subsequently hold a conference call
that same day at 4:30 pm Eastern Time hosted by
Mr. Alexei Marko, Chief Executive Officer, and Mr. Chris
Clark, Chief Financial Officer. A question and answer session will
follow the corporate update.
Conference Call
Details
|
|
DATE:
|
Tuesday, November 14,
2017
|
TIME:
|
4:30 pm ET
|
DIAL-IN
NUMBER:
|
888 390 0605 or 416
764 8609
|
A link to the live audio webcast of the conference call will
also be available on the Presentations and Events page of the
Investors section of Neovasc's website at
www.neovasc.com. Please connect at least 15 minutes prior to the
conference call to ensure adequate time for any software download
that may be required to hear the webcast.
A recording of the call will be available for 72 hours by
calling 888 390 0541 or 416 764 8677 and using passcode
762334#.
About Neovasc Inc.
Neovasc is a specialty medical device company that develops,
manufactures and markets products for the rapidly growing
cardiovascular marketplace. Its products include the Neovasc
Reducer™, for the treatment of refractory angina which is not
currently available in the United
States and has been available in Europe since 2015 and the Tiara™, for the
transcatheter treatment of mitral valve disease, which is currently
under investigation in the United
States, Canada and
Europe. The Company also sells a
line of advanced biological tissue products that are used as key
components in third-party medical products including transcatheter
heart valves. For more information, visit: www.neovasc.com.
SOURCE Neovasc Inc.